## Posttransplant lymphoproliferative disorder (PTLD) is a common and lifethreatening complication of immunosuppression used to prevent rejection of solid organ and bone marrow transplants. There is no standardized treatment algorithm, but numerous management strategies are available. We describe a
β¦ LIBER β¦
Lymphoma resembling hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient
β Scribed by Michael A. Nalesnik; Parmjeet Randhawa; A. Jake Demetris; Joseph Locker; Adrian Casavilla; John J. Fung
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 715 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Use of radiation therapy in posttranspla
β
B.H. Koffman; A.S. Kennedy; M. Heyman; J. Colonna; C. Howell
π
Article
π
2000
π
John Wiley and Sons
π
French
β 328 KB
π 2 views
Gastrointestinal Involvement of Posttran
β
David Shitrit; Ariella Bar-Gil Shitrit; Ram Dickman; Gidon Sahar; Milton Saute;
π
Article
π
2005
π
Springer
π
English
β 126 KB
The pediatric end-stage liver disease (P
β
Neal R. Barshes; Timothy C. Lee; Ian W. Udell; Christine A. O'Mahoney; Saul J. K
π
Article
π
2006
π
John Wiley and Sons
π
English
β 190 KB
π 1 views
The pediatric end-stage liver disease (PELD) model accurately estimates 90-day waitlist mortality for pediatric liver transplant candidates, but it has been unclear if PELD can identify patients who will derive survival benefit from undergoing liver transplantation (LT), if it correlates with posttr
EpsteinβBarr virus-associated T/NK cell-
β
Nobuhiko Omori; Hisashi Narai; Tomotaka Tanaka; Shinichiro Tanaka; Ichiro Yamado
π
Article
π
2007
π
Springer US
π
English
β 229 KB